SUPPLEMENT
Q2 2026 — Financial statement information
Q2 2026PDF · 16 pages190 KB
Three months ended
June 30,
Six months ended
June 30,
2026 2025 2026 2025
Net sales $ 6,500 $ 6,344 $ 12,530 $ 12,298
Operating expenses
Cost of sales 3,817 3,646 7,391 7,124
Selling, general and administrative expenses 1,061 1,267 1,805 2,212
Research, development and related expenses 302 288 610 573
Loss on business divestitures 336 3 343 3
Total operating expenses 5,516 5,204 10,149 9,912
Operating income 984 1,140 2,381 2,386
Other expense (income), net (136) 217 383 78
Income before income taxes 1,120 923 1,998 2,308
Provision for income taxes 183 245 404 510
Income of consolidated group 937 678 1,594 1,798
Income from unconsolidated subsidiaries, net of taxes 1 47 3 49
Net income including noncontrolling interest 938 725 1,597 1,847
Less: net income attributable to noncontrolling interest 5 2 11 8
Net income attributable to 3M $ 933 $ 723 $ 1,586 $ 1,839
Earnings per share attributable to 3M common shareholders:
Weighted average 3M common shares outstanding — basic 519.7 537.4 524.4 540.6
Earnings per share — basic $ 1.79 $ 1.35 $ 3.02 $ 3.40
Weighted average 3M common shares outstanding — diluted 522.4 540.6 527.6 544.2
Earnings per share — diluted $ 1.78 $ 1.34 $ 3.01 $ 3.38
3M Company and Subsidiaries
CONSOLIDATED STATEMENT OF INCOME
(Millions, except per-share amounts)
(Unaudited)
1
-- 1 of 16 --
June 30, 2026 December 31, 2025
Assets
Current assets
Cash and cash equivalents $ 2,955 $ 5,235
Marketable securities 375 698
Accounts receivable – net 3,927 3,533
Inventories 3,770 3,661
Prepaids 492 391
Assets held for sale — 46
Other current assets 2,593 2,823
Total current assets 14,112 16,387
Property, plant and equipment – net 6,877 7,101
Goodwill and intangible assets – net 7,427 7,522
Other assets 6,508 6,723
Total assets $ 34,924 $ 37,733
Liabilities and equity
Current liabilities
Short-term borrowings and current portion of long-term debt $ 1,647 $ 1,670
Accounts payable 3,108 2,702
Accrued payroll 522 718
Liabilities held for sale — 55
Other current liabilities 6,102 4,450
Total current liabilities 11,379 9,595
Long-term debt 10,904 10,932
Other liabilities 9,636 12,459
Total liabilities 31,919 32,986
Total equity 3,005 4,747
Shares outstanding
June 30, 2026: 515,722,417
December 31, 2025: 530,279,131
Total liabilities and equity $ 34,924 $ 37,733
3M Company and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEET
(Dollars in millions)
(Unaudited)
2
-- 2 of 16 --
Six months ended June 30,
2026 2025
Net cash provided by (used in) operating activities $ 1,560 $ (1,033)
Cash flows from investing activities:
Purchases of property, plant and equipment (448) (444)
Purchases and proceeds from sale or maturities of marketable securities and
investments – net 328 1,711
Proceeds from (payments for) sale of businesses, net of cash sold (326) 5
Other investing activities 23 18
Net cash provided by (used in) investing activities (423) 1,290
Cash flows from financing activities:
Change in debt – net — (151)
Purchases of treasury stock and dividends paid to shareholders (3,806) (3,013)
Proceeds from issuances of treasury stock pursuant to stock option and benefit plans 364 988
Other financing activities (16) (15)
Net cash provided by (used in) financing activities (3,458) (2,191)
Effect of exchange rate changes on cash and cash equivalents (5) 46
Net increase (decrease) in cash and cash equivalents, including cash classified within
assets held for sale (2,326) (1,888)
Less: net increase (decrease) in cash classified within assets held for sale (46) —
Net increase (decrease) in cash and cash equivalents (2,280) (1,888)
Cash and cash equivalents at beginning of year 5,235 5,600
Cash and cash equivalents at end of period $ 2,955 $ 3,712
3M Company and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
(Unaudited)
3
-- 3 of 16 --
Three months ended June 30, 2026
By reportable business segment Organic sales Divestitures Translation Total sales
change
Safety and Industrial 8.2 % (1.3) % 1.3 % 8.2 %
Transportation and Electronics 5.9 (0.2) 0.5 6.2
Consumer (2.1) — 0.3 (1.8)
Total reportable business segments 5.3 (0.7) 0.9 5.5
Total Company 2.3 (0.6) 0.7 2.4
By geographic area
United States and Canada — % (0.5) % — % (0.5) %
Latin America 5.4 (0.3) 6.0 11.1
China 9.2 (0.5) 5.2 13.9
Other Asia 2.9 (0.2) (4.3) (1.6)
Europe, Middle East and Africa 2.3 (1.8) 2.7 3.2
Six months ended June 30, 2026
By reportable business segment Organic sales Divestitures Translation Total sales
change
Safety and Industrial 5.7 % (0.7) % 2.5 % 7.5 %
Transportation and Electronics 2.9 (0.3) 1.5 4.1
Consumer (1.7) — 1.0 (0.7)
Total reportable business segments 3.3 (0.4) 1.8 4.7
Total Company 0.5 (0.4) 1.8 1.9
By geographic area
United States and Canada (1.1) % (0.3) % 0.1 % (1.3) %
Latin America 0.8 (0.2) 5.9 6.5
China 6.9 (0.2) 4.6 11.3
Other Asia 1.6 (0.1) (2.3) (0.8)
Europe, Middle East and Africa (0.4) (0.9) 6.2 4.9
3Total sales change is calculated based on reported sales results. The components of sales change include organic local-currency sales,
acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition
and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months
post-transaction.
3M Company and Subsidiaries
SALES CHANGE ANALYSIS3
(Unaudited)
4
-- 4 of 16 --
3M discloses business segment operating income as its measure of segment profit, which is reconciled to both total 3M
operating income and income before taxes. This measure excludes certain expenses and income not allocated to business
segments (as described below in “Corporate”).
Effective in the first and second quarters of 2026, the measure of segment operating performance and segment composition
used by 3M’s chief operating decision maker (CODM) changed. As a result, 3M’s disclosed measure of segment profit and
other segment-related amounts were updated to reflect these changes for all periods presented. The changes include the
following items now reflected within Corporate:
• Effective first quarter 2026—manufactured PFAS products activity and net costs for respirator mask/asbestos
litigation special items: These special items were moved into Corporate from the Transportation and Electronics
segment and Safety and Industrial segment, respectively.
• Effective second quarter 2026—business acquisition-related costs: These costs are now reflected as a Corporate
special item rather than within reportable business segment operating income. There were no such material costs in
prior periods presented.
Three months ended
June 30, Six months ended
June 30,
Net sales (millions) 2026 2025 2026 2025
Abrasives $ 342 $ 338 $ 691 $ 655
Automotive Aftermarket 283 291 587 581
Electrical Markets 391 349 747 674
Industrial Adhesives and Tapes 642 568 1,246 1,111
Industrial Specialties Division 326 294 612 582
Personal Safety 965 882 1,877 1,732
Roofing Granules 142 135 261 267
Total Safety and Industrial business segment 3,091 2,857 6,021 5,602
Advanced Materials 162 148 309 291
Automotive and Aerospace 485 474 969 949
Commercial Branding and Transportation 737 689 1,377 1,305
Electronics 682 633 1,259 1,215
Total Transportation and Electronics business segment 2,066 1,944 3,914 3,760
Consumer Safety and Well-Being 289 280 567 554
Home and Auto Care 318 306 646 605
Home Improvement 362 374 673 700
Packaging and Expression 278 310 492 535
Total Consumer business segment 1,247 1,270 2,378 2,394
Total reportable business segments 6,404 6,071 12,313 11,756
Corporate 96 273 217 542
Total Company $ 6,500 $ 6,344 $ 12,530 $ 12,298
3M Company and Subsidiaries
BUSINESS SEGMENTS
(Unaudited)
5
-- 5 of 16 --
Three months ended
June 30, Six months ended
June 30,
Operating income (millions) 2026 2025 2026 2025
Safety and Industrial $ 859 $ 738 $ 1,635 $ 1,437
Transportation and Electronics 503 479 902 869
Consumer 252 268 469 487
Total reportable business segments 1,614 1,485 3,006 2,793
Corporate
Corporate-level (expense) income 1 22 35 72
Corporate special items:
Net costs for significant litigation and PFAS exit (183) (347) (13) (421)
Business acquisition-related costs (12) — (12) —
(Loss) gain on business divestitures (336) (3) (343) (3)
Manufactured PFAS products — (17) (126) (55)
Transformation costs (100) — (166) —
Total Corporate (630) (345) (625) (407)
Total Company operating income 984 1,140 2,381 2,386
Other expense/(income), net (136) 217 383 78
Income before income taxes $ 1,120 $ 923 $ 1,998 $ 2,308
Corporate
Outside of 3M's reportable segments, 3M has Corporate, which is not a reportable business segment as it does not meet the
segment reporting criteria. Because Corporate includes a variety of miscellaneous items, it is subject to fluctuation on a
quarterly and annual basis.
Corporate operating income (loss) includes:
• Corporate-level (expense) income includes:
◦ certain enterprise and governance activities resulting in unallocated corporate costs and other activity or costs
that 3M may choose not to allocate directly to its business segments,
◦ commercial activity with Solventum following its April 2024 spin-off from 3M, as well as certain operations
of 3M’s former health care business segment that were retained by 3M, and
◦ transition arrangement agreements (e.g., fees charged by 3M, net of underlying costs) related to divested
businesses, including those related to Solventum.
• Corporate special items include, for the periods presented:
◦ net costs for significant litigation and PFAS exit impacting operating income (loss),
◦ business acquisition-related costs,
◦ manufactured PFAS products activity,
◦ (loss) gain on business divestitures, and
◦ transformation program restructuring and related charges.
3M Company and Subsidiaries
BUSINESS SEGMENTS - (CONTINUED)
(Unaudited)
6
-- 6 of 16 --
In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These
measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly
titled measures used by other companies.
Certain measures adjust for the impact of special items. Special items for the periods presented include the items described in
the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments,
it is noteworthy that special items impacting operating income (loss) are reflected in Corporate.
This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for
special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and
reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include:
GAAP amounts for which a measure adjusted for
special items is also provided: Reasons 3M believes the measure is useful:
• Net sales (and sales change)
Considered in evaluating and managing operations; useful in
understanding underlying business performance, provides additional
transparency to special items
• Operating income (loss) and operating income
(loss) margin (and expansion)
• Income before taxes
• Provision for income taxes and effective tax rate
• Net income
• EPS
Additional non-GAAP measures:
• Adjusted net cash provided by (used in)
operating activities; adjusted purchases of
property, plant and equipment (also referred to as
adjusted capital expenditures); adjusted free cash
flow and adjusted free cash flow conversion
Used as indicators of strength and ability to generate cash and as
indicator of capital deployment; meaningful as measures of
performance
The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)
7
-- 7 of 16 --
Certain amounts adjusted for special items (non-GAAP measures):
(Dollars in millions, except per share amounts)
Three months ended June 30, 2025
Net sales
Operating
income
Operating
income
margin
Income
before
taxes
Provision
for income
taxes Effective
tax rate
Net income
attributable
to 3M EPS
Total Company GAAP amounts $ 6,344 $ 1,140 18.0 % $ 923 $ 245 26.6 % $ 723 $ 1.34
Corporate GAAP amounts $ 273 $ (345)
Adjustments for special items:
Net costs for significant litigation and PFAS
exit — 347 471 46 425 0.79
Loss on business divestitures — 3 3 1 2 —
Manufactured PFAS products (186) 17 17 4 13 0.02
Solventum ownership - change in value — — 7 — 7 0.01
Total special items (186) 367 498 51 447 0.82
Total Company adjusted amounts (non-GAAP
measures)4 $ 6,158 $ 1,507 24.5 % $ 1,421 $ 296 20.8 % $ 1,170 $ 2.16
Corporate adjusted amounts (non-GAAP
measures)4 $ 87 $ 22
(Dollars in millions, except per share amounts)
Three months ended June 30, 2026
Operating
income
Operating
income
margin
Operating
income
margin
expansion
Income
before
taxes
Provision
for income
taxes Effective
tax rate
Net income
attributable
to 3M EPS
EPS
percent
change
Total Company GAAP amounts $ 984 15.1 % (290) bps $ 1,120 $ 183 16.3 % $ 933 $ 1.78 33 %
Corporate GAAP amounts $ (630)
Adjustments for special items:
Net costs for significant litigation and PFAS
exit 183 296 64 232 0.44
Business acquisition-related costs 12 12 — 12 0.02
Loss on business divestitures 336 336 20 316 0.61
Solventum ownership - change in value — (303) 11 (314) (0.60)
Transformation costs 100 100 24 76 0.15
Total special items 631 441 119 322 0.62
Total Company adjusted amounts (non-GAAP
measures)4 $ 1,615 24.9 % 40 bps $ 1,561 $ 302 19.3 % $ 1,255 $ 2.40 11 %
Corporate adjusted amounts (non-GAAP
measures)4 $ 1
4These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
8
-- 8 of 16 --
Six months ended June 30, 2025
(Dollars in millions, except per share amounts) Net sales
Operating
income
Operating
income
margin
Income
before taxes
Provision
for income
taxes Effective
tax rate
Net income
attributable
to 3M EPS
Total Company GAAP amounts $ 12,298 $ 2,386 19.4 % $ 2,308 $ 510 22.1 % $ 1,839 $ 3.38
Corporate GAAP amounts $ 542 $ (407)
Adjustments for special items:
Net costs for significant litigation and PFAS
exit — 421 695 44 651 1.20
Loss on business divestitures — 3 3 1 2 —
Manufactured PFAS products (360) 55 55 13 42 0.08
Solventum ownership - change in value — — (336) — (336) (0.62)
Total special items (360) 479 417 58 359 0.66
Total Company adjusted amounts (non-GAAP
measures)4 $ 11,938 $ 2,865 24.0 % $ 2,725 $ 568 20.9 % $ 2,198 $ 4.04
Corporate adjusted amounts (non-GAAP
measures)4 $ 182 $ 72
Six months ended June 30, 2026
(Dollars in millions, except per share
amounts)
Net
sales
Sales
change
Operating
income
Operating
income
margin
Operating
income
margin
expansion
Income
before
taxes
Provision
for
income
taxes Effective
tax rate
Net income
attributable
to 3M EPS
EPS
percent
change
Total Company GAAP amounts $ 12,530 1.9 % $ 2,381 19.0 % (40) bps $ 1,998 $ 404 20.2 % $ 1,586 $ 3.01 (11) %
Corporate GAAP amounts $ 217 $ (625)
Adjustments for special items:
Net costs for significant litigation
and PFAS exit — 13 251 39 212 0.40
Business acquisition-related costs — 12 12 — 12 0.02
Loss on business divestitures — 343 343 21 322 0.61
Manufactured PFAS products (27) 126 126 31 95 0.18
Solventum ownership - change in
value — — 53 11 42 0.08
Transformation costs — 166 166 40 126 0.24
Total special items (27) 660 951 142 809 1.53
Total Company adjusted amounts
(non-GAAP measures)4 $ 12,503 4.7 % $ 3,041 24.3 % 30 bps $ 2,949 $ 546 18.5 % $ 2,395 $ 4.54 12 %
Corporate adjusted amounts (non-
GAAP measures)4 $ 190 $ 35
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
9
-- 9 of 16 --
Amounts from continuing operations
Twelve months ended December 31, 2023 Twelve months ended June 30, 2026
(Dollars in millions, except per share amounts) Net sales
Operating
income (loss)
Operating
income (loss)
margin Net sales
Operating
income
Operating
income
margin
Total Company GAAP amounts $ 24,610 $ (10,689) (43.4) % $ 25,180 $ 4,624 18.4 %
Adjustments for special items:
Net costs for significant litigation and PFAS exit — 14,869 — 133
(Gain)/loss on business divestitures — (36) — 502
Business acquisition-related costs — — — 12
Divestiture costs — 13 — —
Manufactured PFAS products (1,289) 205 (336) 363
Russia exit benefits — (18) — —
Transformation costs — — — 235
Total special items (1,289) 15,033 (336) 1,245
Total Company adjusted amounts (non-GAAP measures)4 $ 23,321 $ 4,344 18.6 % $ 24,844 $ 5,869 23.6 %
2026 forecast
2026 adjusted operating income margin expansion (non-GAAP measure)4,5 70 bps to 80 bps
2026 adjusted earnings per share (non-GAAP measure)4,5 $8.80 to $8.95
2026 adjusted effective tax rate (non-GAAP measure)4,5 ~20%
53M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or
provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant
litigation and PFAS exit; business acquisition-related costs; projected divestiture gains (losses); changes in value of Solventum
ownership; transformation costs; and net sales and estimates of income and associated activity of exited manufactured PFAS products all
of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M
believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M
believes that the probable significance of such information is low. Additionally, for similar reasons, 3M does not include the impact of
potentially-divested or acquired businesses on expected operations in forecasted guidance it provides until close of a transaction, unless
otherwise indicated. Information with respect to special items for certain historical periods is included in the section entitled “Description
of special items”.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
10
-- 10 of 16 --
Three months ended June 30, 2026
Sales change3 Organic sales Divestitures Translation Total sales
change
Total Company 2.3 % (0.6) % 0.7 % 2.4 %
Remove manufactured PFAS products special item impact 3.1 (0.1) 0.1 3.1
Adjusted total Company (non-GAAP measures)4 5.4 % (0.7) % 0.8 % 5.5 %
By geographic area
United States and Canada — % (0.5) % — % (0.5) %
Remove manufactured PFAS products special item impact 2.4 — — 2.4
Adjusted United States and Canada (non-GAAP measures)4 2.4 % (0.5) % — % 1.9 %
Latin America 5.4 % (0.3) % 6.0 % 11.1 %
Remove manufactured PFAS products special item impact 0.5 — — 0.5
Adjusted Latin America (non-GAAP measures)4 5.9 % (0.3) % 6.0 % 11.6 %
China 9.2 % (0.5) % 5.2 % 13.9 %
Remove manufactured PFAS products special item impact 2.5 — — 2.5
Adjusted China (non-GAAP measures)4 11.7 % (0.5) % 5.2 % 16.4 %
Other Asia 2.9 % (0.2) % (4.3) % (1.6) %
Remove manufactured PFAS products special item impact 6.2 — (0.3) 5.9
Adjusted Other Asia (non-GAAP measures)4 9.1 % (0.2) % (4.6) % 4.3 %
Europe, Middle East & Africa 2.3 % (1.8) % 2.7 % 3.2 %
Remove manufactured PFAS products special item impact 3.6 (0.1) 0.1 3.6
Adjusted Europe, Middle East & Africa (non-GAAP measures)4 5.9 % (1.9) % 2.8 % 6.8 %
By particular country
United States (0.1) % (0.4) % — % (0.5) %
Remove manufactured PFAS products special item impact 2.6 — — 2.6
Adjusted United States (non-GAAP measures)4 2.5 % (0.4) % — % 2.1 %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
11
-- 11 of 16 --
Six months ended June 30, 2026
Sales change3 Organic sales Divestitures Translation Total sales
change
Total Company 0.5 % (0.4) % 1.8 % 1.9 %
Remove manufactured PFAS products special item impact 2.8 — — 2.8
Adjusted total Company (non-GAAP measures)4 3.3 % (0.4) % 1.8 % 4.7 %
By geographic area
United States and Canada (1.1) % (0.3) % 0.1 % (1.3) %
Remove manufactured PFAS products special item impact 2.7 — — 2.7
Adjusted United States and Canada (non-GAAP measures)4 1.6 % (0.3) % 0.1 % 1.4 %
Latin America 0.8 % (0.2) % 5.9 % 6.5 %
Remove manufactured PFAS products special item impact 0.5 — — 0.5
Adjusted Latin America (non-GAAP measures)4 1.3 % (0.2) % 5.9 % 7.0 %
China 6.9 % (0.2) % 4.6 % 11.3 %
Remove manufactured PFAS products special item impact 1.0 (0.1) 0.2 1.1
Adjusted China (non-GAAP measures)4 7.9 % (0.3) % 4.8 % 12.4 %
Other Asia 1.6 % (0.1) % (2.3) % (0.8) %
Remove manufactured PFAS products special item impact 5.2 — (0.2) 5.0
Adjusted Other Asia (non-GAAP measures)4 6.8 % (0.1) % (2.5) % 4.2 %
Europe, Middle East & Africa (0.4) % (0.9) % 6.2 % 4.9 %
Remove manufactured PFAS products special item impact 3.0 (0.1) 0.3 3.2
Adjusted Europe, Middle East & Africa (non-GAAP measures)4 2.6 % (1.0) % 6.5 % 8.1 %
By particular country
United States (1.6) % (0.3) % — % (1.9) %
Remove manufactured PFAS products special item impact 2.9 — — 2.9
Adjusted United States (non-GAAP measures)4 1.3 % (0.3) % — % 1.0 %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
12
-- 12 of 16 --
Twelve months ended December 31, 2023
Sales change3
Organic
sales Acquisitions Divestitures Translation Total sales
change
Total Company (4.3) % 0.3 % (1.2) % (0.7) % (5.9) %
Remove manufactured PFAS products special item impact (0.1) — (0.1) 0.1 (0.1)
Adjusted total Company (non-GAAP measures)4 (4.4) % 0.3 % (1.3) % (0.6) % (6.0) %
Twelve months ended June 30, 2024
Sales change3
Organic
sales Acquisitions Divestitures Translation Total sales
change
Total Company (2.1) % 0.4 % (0.1) % (0.2) % (2.0) %
Remove manufactured PFAS products special item impact 0.9 — — — 0.9
Adjusted total Company (non-GAAP measures)4 (1.2) % 0.4 % (0.1) % (0.2) % (1.1) %
Twelve months ended December 31, 2024
Sales change3
Organic
sales Acquisitions Divestitures Translation Total sales
change
Total Company (0.2) % 0.2 % 0.6 % (0.7) % (0.1) %
Remove manufactured PFAS products special item impact 1.4 — 0.1 (0.1) 1.4
Adjusted total Company (non-GAAP measures)4 1.2 % 0.2 % 0.7 % (0.8) % 1.3 %
Twelve months ended June 30, 2025
Sales change3
Organic
sales Acquisitions Divestitures Translation Total sales
change
Total Company 0.1 % — % 0.7 % (0.6) % 0.2 %
Remove manufactured PFAS products special item impact 1.4 — — 0.1 1.5
Adjusted total Company (non-GAAP measures)4 1.5 % — % 0.7 % (0.5) % 1.7 %
Twelve months ended December 31, 2025
Sales change3
Organic
sales Acquisitions Divestitures Translation Total sales
change
Total Company 0.9 % — % 0.2 % 0.4 % 1.5 %
Remove manufactured PFAS products special item impact 1.2 — — — 1.2
Adjusted total Company (non-GAAP measures)4 2.1 % — % 0.2 % 0.4 % 2.7 %
Twelve months ended June 30, 2026
Sales change3
Organic
sales Acquisitions Divestitures Translation Total sales
change
Total Company 1.1 % — % (0.2) % 1.4 % 2.3 %
Remove manufactured PFAS products special item impact 1.9 — — 0.1 2.0
Adjusted total Company (non-GAAP measures)4 3.0 % — % (0.2) % 1.5 % 4.3 %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
13
-- 13 of 16 --
2026 forecast
Sales change3 Organic sales Acquisitions Divestitures Translation Total sales change
Total Company5 >3.5% — % — % ~1% >4.5%
Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also
referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non-
GAAP measures):
Three months ended
June 30,
Six months ended
June 30,
Major GAAP cash flow categories (dollars in millions) 2026 2025 2026 2025
Net cash provided by (used in) operating activities $ 986 $ (954) $ 1,560 $ (1,033)
Net cash provided by (used in) investing activities (483) 70 (423) 1,290
Net cash provided by (used in) financing activities (1,334) (1,769) (3,458) (2,191)
Three months ended
June 30,
Six months ended
June 30,
Adjusted free cash flow (non-GAAP measure) (dollars in millions) 2026 2025 2026 2025
Net cash provided by (used in) operating activities $ 986 $ (954) $ 1,560 $ (1,033)
Adjustments for special items:
Net costs/(recoveries) for significant litigation and PFAS exit after-tax
payment impacts
574 2,216 683 3,003
Divestiture costs after-tax payment impacts — 43 — 59
TCJA transition tax payment — 211 — 211
Transformation actions after-tax payment impacts 11 — 43 —
Manufactured PFAS products after-tax payment impacts — (25) 51 (32)
Total adjustments for special items 585 2,445 777 3,241
Adjusted net cash provided by (used in) operating activities (non-GAAP
measure)6
$ 1,571 $ 1,491 $ 2,337 $ 2,208
Purchases of property, plant and equipment (PPE) (223) (208) (448) (444)
Manufactured PFAS products impact - removing related purchases of
PPE
— 1 — 9
Adjusted purchases of PPE (non-GAAP measure)6 $ (223) $ (207) $ (448) $ (435)
Adjusted free cash flow (non-GAAP measure)6 $ 1,348 $ 1,284 $ 1,889 $ 1,773
Adjusted net income attributable to 3M4 $ 1,255 $ 1,170 $ 2,395 $ 2,198
Adjusted free cash flow conversion (non-GAAP measure)6 107 % 110 % 79 % 81 %
63M defines adjusted net cash provided by (used in) operating activities as net cash provided by operating activities, adjusted for special
items. 3M defines adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures) as purchases of
property, plant and equipment (PPE) adjusted for the estimated impact of such purchases associated with manufactured PFAS products
activity. 3M defines adjusted free cash flow as adjusted net cash provided by (used in) operating activities less adjusted purchases of PPE.
Cash payments/receipts associated with special items in the determination of adjusted net cash provided by (used in) operating activities are
reflected net of applicable tax. The cash tax impact is determined by the amount, timing, and applicable tax rates for the actual cash tax
payments, which may differ from the timing of the related pre-tax cash payments or underlying transactions. 3M defines adjusted free cash
flow conversion as adjusted free cash flow divided by net income attributable to 3M, adjusted for special items (used for adjusted free cash
flow conversion calculation).
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
14
-- 14 of 16 --
(Dollars in billions) 2026 forecast
Net cash provided by (used in) operating activities $5.8 to $6.0
Adjustments for special items5 —
Adjusted net cash provided by (used in) operating activities (non-GAAP measure)5,6 $5.8 to $6.0
Purchase of property, plant and equipment (PPE) ~$1.1
Adjusted free cash flow (non-GAAP measure)5,6 $4.7 to $4.9
Net income attributable to 3M $4.6 to $4.7
Adjustments for special items5 —
Adjusted net income attributable to 3M (non-GAAP measure)4,5 $4.6 to $4.7
Adjusted free cash flow conversion (non-GAAP measure)5,6 >100%
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
15
-- 15 of 16 --
Description of special items:
In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP
measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these
non-GAAP measures for the periods presented include the items described below:
Net costs for significant litigation and PFAS exit:
• Net costs for significant litigation relate to 3M's respirator mask/asbestos (which include Aearo and non-Aearo items),
PFAS-related other environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in
accrued liabilities (including interest imputation on applicable settlement obligations), legal costs, and insurance
recoveries, along with the associated tax impacts. Associated tax impacts of significant litigation include impacts on
Foreign-Derived Deduction Eligible Income ("FDDEI"), Net Controlled Foreign Corporation Tested Income ("NCTI"),
foreign tax credits, and tax costs of repatriation. PFAS exit costs include amounts outside of significant litigation related
to impacted site disposition and treatment post-first quarter 2026 completion of substantive PFAS product sales. 3M does
not consider the elements of the net costs associated with these matters to be normal, operating expenses related to the
Company’s ongoing operations, revenue generating activities, business strategy, industry, and regulatory environment. In
the second quarter of 2026 and 2025, 3M reflected net pre-tax cash (receipts)/payments of $858 million and $2,509
million, respectively, related to net costs for significant litigation and PFAS exit. In the first six months of 2026 and 2025,
3M reflected net pre-tax cash (receipts)/payments of $960 million and $3,315 million, respectively, related to net costs for
significant litigation and PFAS exit.
Business acquisition-related costs:
• These include transaction and integration costs as applicable in the respective periods.
Gain/loss on business divestitures:
• In the third quarter of 2025, 3M classified a business as held for sale. In the first half of 2026, 3M reflected an adjustment
to carrying it at its selling price less cost to sell. In the second quarter of 2026, 3M recorded a loss on the divestiture of its
Dyneon GmbH subsidiary. In June 2025, 3M completed a divestiture for immaterial proceeds slightly below the business’
book value. In 2023, 3M recorded a gain related to the sale of its dental local anesthetic business partially offset by a loss
associated with a contingent indemnification obligation from an earlier divestiture.
Divestiture costs:
• These include limited costs that were not eligible to be included within discontinued operations related to separating and
divesting substantially an entire business segment of 3M following public announcement of its intended divestiture.
Russia exit benefits
• In 2023, 3M recorded a gain on final disposal of net assets in Russia.
Manufactured PFAS products:
• These amounts relate to sales and income (loss) and associated activity regarding manufactured PFAS products that 3M
exited by the end of 2025. Income does not contemplate impacts on non-operating items such as net interest income/
expense and the non-service cost components portion of defined benefit plan net periodic benefit costs. Relative to the
impact of the activity of manufactured PFAS products on cash provided by (used in) operating activities, amounts are
based on estimates of associated income, depreciation, certain changes in working capital and accruals, and timing of
associated payments.
Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA):
• In the second quarter of 2025, 3M made payments of $211 million related to the transition tax expense incurred as a result
of the 2017 enactment of the TCJA.
Solventum ownership - change in value:
• This amount relates to the change in value of 3M's retained ownership interest in Solventum common stock reflected in
other expense (income), net.
Transformation costs:
• These represent net costs associated with 3M's transformation program, intended as a structural redesign of longer-term
manufacturing, distribution, and business process services and locations. Accordingly, 3M does not consider the nature or
effect of this program to be normal, operating expenses related to the Company’s ongoing operations, revenue generating
activities, and day-to-day business strategy. Net costs include restructuring and other related items such as site closure,
sale, moving and set-up, accelerated depreciation, and program management. In the second quarter and first six months of
2026, 3M made pre-tax cash payments of $41 million and $73 million, respectively, associated with transformation costs.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
16
-- 16 of 16 --